Pediatric Hematology and Oncology
Overview
Pediatric Hematology and Oncology is a peer-reviewed journal that focuses on the diagnosis, treatment, and management of blood disorders and cancers in children. It provides a platform for researchers, clinicians, and healthcare professionals to share their latest findings, advancements, and clinical experiences in the field. The journal covers a wide range of topics including leukemia, lymphoma, hemophilia, sickle cell disease, and other pediatric hematologic and oncologic conditions. It aims to improve the understanding, care, and outcomes for children with these diseases through high-qualit
Details
Details
Abbr.
Pediatr Hematol Oncol
Publisher
Informa Healthcare
Start
1986
End
Continuing
Frequency
Eight no. a year, <2003>-
p-ISSN
0888-0018
e-ISSN
1521-0669
Country
United Kingdom
Language
English
Specialty
Pediatrics
Metrics
Metrics
h-index / Ranks: 7562
48
SJR / Ranks: 9796
439
CiteScore / Ranks: 9213
2.70
JIF / Ranks: 5746
1.7
Recent Articles
1.
Luckie T, Chelius D, Dimachkieh A, Quintanilla N, Roy A, Sher A, et al.
Pediatr Hematol Oncol
. 2025 Mar;
:1-6.
PMID: 40028664
No abstract available.
2.
Wong Z, Ou K, Wong Z, Faderani R, Kanapathy M, Mosahebi A
Pediatr Hematol Oncol
. 2025 Feb;
:1-11.
PMID: 39989269
Cutaneous melanoma (CM) is a rare occurrence in the pediatric population and suffers from a dearth of epidemiological data. This study aims to estimate the distribution and temporal trends of...
3.
Park M, Ju H, Lee J, Yoo K, Kim H, Cho D, et al.
Pediatr Hematol Oncol
. 2025 Feb;
42(2):115-125.
PMID: 39945241
Measurable residual disease (MRD) is critical in guiding therapeutic strategies for B-cell acute lymphoblastic leukemia (B-ALL). This study evaluated the performance of a novel next-generation sequencing-based Celemics IGH assay (CM-IGH;...
4.
Malhotra P, Jain S, Sharma R, Pahuja A, Goyal R, Sharma A, et al.
Pediatr Hematol Oncol
. 2025 Feb;
42(2):104-114.
PMID: 39921217
Pulmonary toxicity is one of the most common morbidities experienced by childhood cancer survivors (CCS). The aim of this study was to identify prevalence, pattern of dysfunction, and risk factors...
5.
Iyer P
Pediatr Hematol Oncol
. 2025 Jan;
42(2):126-145.
PMID: 39889807
Pediatric acute myeloid leukemia (AML) is a heterogeneous and aggressive hematological malignancy. Despite advances in treatment, the survival rates remain unsatisfactory, emphasizing the need for innovative therapeutic approaches. This narrative...
6.
Vilela T, Fisberg M, Ferrari G, Braga J
Pediatr Hematol Oncol
. 2025 Jan;
42(2):92-103.
PMID: 39819371
Pediatric patients with sickle cell disease and vitamin D deficiency have worse clinical and laboratory outcomes. This study aims to quantify the prevalence of vitamin D deficiency in this population...
7.
Batista N, Corrigan M, Chen J
Pediatr Hematol Oncol
. 2024 Dec;
42(1):54-62.
PMID: 39673074
Radiation therapy targets tumor tissue and requires children to lay still, often necessitating sedation. Historically anesthesiologists provided procedural sedation, but pediatric critical care physicians now regularly administer sedation outside the...
8.
Tantoco A, Badawy S, Lee C, Merz J, Steed M, Kluk M, et al.
Pediatr Hematol Oncol
. 2024 Dec;
42(2):69-78.
PMID: 39659207
Hospitalized patients with sickle cell disease (SCD) may use opioid medications for both acute and chronic pain management. Use of these medications may unintentionally generate diagnostic codes for opioid misuse...
9.
Garcia Leon J, DiCristina C, Yao R, Afzal A
Pediatr Hematol Oncol
. 2024 Dec;
42(2):79-91.
PMID: 39655741
Convenient multiday dosing of antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting (CINV) are needed in pediatric patients, who are more likely than adults to be treated with...
10.
Scanlon S, Dzara K, Ronsley R
Pediatr Hematol Oncol
. 2024 Dec;
42(1):27-36.
PMID: 39648352
Application of evidenced-based practices is often lacking in medical education. Increased recognition that methods of knowledge delivery based in relevant learning theories are more effective has led to improved ability...